Tumour suppressor genes

Written by

in

 

Tumor Suppressor Genes: Cellular Gatekeepers

Tumor suppressor genes encode proteins that normally regulate cell division, repair DNA replication errors, or initiate programmed cell death (apoptosis). Unlike proto-oncogenes, which require only a single activating mutation to drive oncogenesis, tumor suppressor genes generally follow Knudson’s two-hit hypothesis. This means malignancy requires a loss-of-function mutation in both alleles (homozygous inactivation) to eliminate the protective braking system of the cell.

1. The Molecular Gatekeepers: p53 and Rb Pathways

The two most frequently altered tumor suppressor networks coordinate cell cycle checkpoints in response to intracellular stress and genomic damage:

Cell signaling pathway diagram highlighting DNA damage activating p53 to upregulate p21 which inhibits CDK complexes, alongside p16 inhibiting CDKs to keep RB hypophosphorylated and bound to E2F to arrest the cell cycle

Interconnected control of the cell cycle: Activation of p53 drives p21-mediated CDK inhibition, while active RB remains bound to E2F to prevent unauthorized transition from G1 to S phase.
  • TP53 (Guardian of the Genome):
    Encodes the p53 transcription factor, which is continuously degraded by MDM2 under basal conditions. In response to DNA damage, protein kinases phosphorylate and stabilize p53. Once stable, p53 upregulates p21 (a cyclin-dependent kinase inhibitor) to arrest the cell cycle at the G1-to-S transition, allowing time for DNA repair. If the damage is too severe, p53 activates pro-apoptotic genes like BAX to induce mitochondrial outer membrane permeabilization and cell death.
  • RB1 (Retinoblastoma Gene):
    Encodes the Rb protein, which serves as a major molecular switch for entry into the S phase. In its unphosphorylated (active) state, Rb binds and sequesters the E2F transcription factor, blocking the expression of replication machinery. When growth factors stimulate Cyclin D-CDK4/6 complexes, Rb becomes hyperphosphorylated, releasing E2F and allowing the cell cycle to advance.

2. High-Yield Tumor Suppressor Genes and Syndromes

Recognizing the primary cellular function, associated clinical syndromes, and corresponding malignancy risks is a classic area of board assessment:

Gene Physiological Function Clinical Syndrome & Associated Malignancies
TP53 Regulates cell cycle arrest (via p21) and apoptosis (via BAX) in response to DNA damage. Li-Fraumeni Syndrome: Autosomal dominant inheritance leading to early-onset sarcomas, breast cancer, brain tumors, leukemia, and adrenal carcinomas.
RB1 Inhibits the E2F transcription factor to halt the cell cycle at the G1/S transition boundary. Familial Retinoblastoma: Presents with white pupillary reflex (leukocoria) in young children. Patients carry a markedly elevated risk for developing osteosarcomas later in life.
APC Degrades beta-catenin within the Wnt signaling pathway, preventing transcription of growth-promoting genes. Familial Adenomatous Polyposis (FAP): Thousands of adenomatous colon polyps developing by early adulthood; inevitable progression to colorectal carcinoma without prophylactic colectomy.
BRCA1 / 2 Participate in the homologous recombination repair pathway for double-stranded DNA breaks. Hereditary Breast and Ovarian Cancer Syndrome: Greatly increased lifetime risk for early-onset invasive ductal carcinoma of the breast, serous ovarian carcinoma, and pancreatic adenocarcinoma.
VHL Forms part of an ubiquitin ligase complex that targets hypoxia-inducible factors (HIF) for degradation. Von Hippel-Lindau Disease: Characterized by bilateral clear cell renal cell carcinomas, cerebellar and retinal hemangioblastomas, and pheochromocytomas.
NF1 / 2 NF1 produces Neurofibromin (a Ras-GAP that inactivates Ras signaling). NF2 produces Merlin (involved in contact inhibition). • NF1: Neurofibromatosis type 1 (Lisch nodules, cafe-au-lait spots, neurofibromas, optic gliomas).
• NF2: Neurofibromatosis type 2 (bilateral vestibular schwannomas, meningiomas, ependymomas).
WT1 Transcription factor critical for normal urogenital development. Wilms Tumor (Nephroblastoma): Most common pediatric renal malignancy. Can occur as part of WAGR syndrome (Wilms, Aniridia, Genitourinary anomalies, intellectual disability) due to a deletion on chromosome 11p13.